Author

Takuya Murakami

Kyoto UniversityORCID 0000-0001-6028-4533Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Takuya Murakami1 paper · The University of Tokyo

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Chikako OkuboiD· 1 shared Kazutoshi TakahashiiD· 1 shared Lu NiiD· 1 shared Mari Hamao· 1 shared Michiko NakamuraiD· 1 shared Satoshi SuzukiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Chikako OkuboORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologybioRxivPreprintMay 14, 2026

Comparative benchmarking of CRISPRi and CasRx in standardized pluripotent stem cell platforms reveals context-dependent knockdown performance

Lu Ni, Takuya Murakami, Satoshi Suzuki…·Kazutoshi Takahashi

This study compares CRISPRi and CasRx for gene knockdown in human pluripotent stem cells, finding CRISPRi provides faster and stronger repression but slower recovery, while CasRx offers reversible knockdown with isoform resolution but lower efficiency.

DOI 10.64898/2026.05.13.724469

humanCRISPR screen

𝕏 PostBluesky